PTSD

Latest News

FDA Advisory Committee Casts Nearly Unanimous Vote Against Otsuka's PTSD Combination

By Grace Halsey

July 21st 2025

The FDA advisory committee overwhelmingly voted against Otsuka's PTSD treatment, citing insufficient evidence from clinical trials for approval.

Otsuka and Lundbeck Will Face Scrutiny Over Investigational PTSD Therapy at July 18 FDA AdComm Meeting

By Grace Halsey

July 17th 2025

Investigational Rapid-Acting PTSD Medication Awarded FDA Breakthrough Therapy Status / image credit ©Feng Yu/stock.adobe.com

Investigational Rapid-Acting PTSD Medication Awarded FDA Breakthrough Therapy Status: Transcend Therapeutics Update

By Grace Halsey

July 10th 2025

FDA to Convene Advisory Committee on Brexpiprazole-Sertraline for Adult PTSD

By Patient Care Editorial Staff

January 10th 2025

sNDA for Brexpiprazole/Sertraline Combination for PTSD Submitted for FDA Review

By Heidi Anne Duerr, MPH

May 3rd 2024

More News

Optimizing PTSD Treatment: The Role of Brexpiprazole and Sertraline in Future Guidelines

Lori Davis, MD;Sydney Jennings

February 3rd 2025

Brexpiprazole and sertraline showed promise for PTSD treatment in a recent study. Lead author, Lori Davis, MD, discusses clinical findings, treatment guidelines, and future research directions.

PTSD Treatment Advancements: Brexpiprazole-Sertraline Offers New Hope in Phase 3 Trial

Lori Davis, MD;Sydney Jennings

January 29th 2025

Data showed that brexpiprazole plus sertraline significantly improved PTSD symptoms vs sertraline alone. Lead author, Lori Davis, MD, discusses more.

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777